Compare VIOT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIOT | STXS |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.2M | 86.4M |
| IPO Year | 2018 | 2004 |
| Metric | VIOT | STXS |
|---|---|---|
| Price | $1.34 | $0.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.67 |
| AVG Volume (30 Days) | 40.7K | ★ 918.4K |
| Earning Date | 08-27-2026 | 11-10-2026 |
| Dividend Yield | ★ 4.89% | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.78 | $27.08 |
| P/E Ratio | $3.56 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.66 | $0.80 |
| 52 Week High | $2.77 | $2.86 |
| Indicator | VIOT | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 40.74 | 35.20 |
| Support Level | $1.23 | $0.80 |
| Resistance Level | $1.52 | $1.97 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 15.00 | 4.35 |
Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.